V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212085 | 20078784 | 1.81 | 71.1 | Palliative (P) | 2018-03-16 | 2018-03-28 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100901597 |
| 20212086 | 20078785 | 1.76 | 68.6 | Neo-adjuvant (N) | 2018-11-26 | 2018-11-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101531828 |
| 20212087 | 20078786 | 0 | 0 | Curative (C) | 2018-09-10 | 2018-09-25 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100366281 |
| 20212088 | 20078787 | 1.76 | 72 | Palliative (P) | 2018-04-22 | 2018-05-16 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 101153534 |
| 20212091 | 20078788 | 1.65 | 87.8 | Palliative (P) | 2019-12-11 | 2020-02-08 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100358140 |
| 20212092 | 20078789 | 1.79 | 0 | null | 2016-09-16 | 2016-10-16 | CISPLATIN + FLUOROURACIL | N | null | CISPLATIN + FLUOROURACIL | 100248789 |
| 20212094 | 20078790 | 1.62 | 60.1 | null | 2018-06-01 | 2018-06-22 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100203168 |
| 20212095 | 20078791 | 0 | 0 | Palliative (P) | 2017-06-10 | 2017-06-14 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101463356 |
| 20212096 | 20078792 | 1.72 | 47.05 | null | 2019-03-30 | 2019-04-09 | CAPECITABINE + CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 101645187 |
| 20212098 | 20078793 | 1.57 | 95.4 | Curative (C) | 2017-04-18 | 2017-04-25 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100311156 |
| 20212099 | 20078794 | 1.72 | 78 | Palliative (P) | 2018-05-01 | 2018-05-18 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100665394 |
| 20212101 | 20078795 | 1.7 | 70 | null | 2021-03-10 | 2021-03-24 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100100272 |
| 20212102 | 20078796 | 1.82 | 43.5 | null | 2019-01-02 | 2019-01-02 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100735373 |
| 20212103 | 20078797 | 1.79 | 54.5 | Neo-adjuvant (N) | 2019-03-24 | 2019-03-24 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101114452 |
| 20212104 | 20078798 | null | null | Palliative (P) | 2018-07-10 | 2018-07-25 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101455533 |
| 20212105 | 20078799 | 1.64 | 110 | Palliative (P) | 2018-10-28 | 2018-10-29 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101106195 |
| 20212106 | 20078800 | 1.69 | 91.6 | Palliative (P) | null | 2017-03-04 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100604540 |
| 20212108 | 20078801 | 1.56 | 77.6 | Neo-adjuvant (N) | 2017-04-25 | 2017-04-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100352970 |
| 20212109 | 20078802 | 1.75 | 94.6 | null | 2018-09-12 | 2018-09-19 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101414463 |
| 20212110 | 20078803 | 1.6 | 74.2 | null | 2016-08-22 | 2016-09-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100093276 |
| 20212111 | 20078804 | 1.73 | 49 | 03 | 2019-08-28 | 2019-09-14 | CAPECITABINE + CARBOPLATIN | N | null | TRIAL UNSPECIFIED | 100919147 |
| 20212112 | 20078805 | 1.71 | 84.5 | Palliative (P) | 2019-05-14 | 2019-06-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101525228 |
| 20212113 | 20078806 | 1.76 | 68.9 | Curative (C) | 2016-03-02 | 2016-03-23 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100447125 |
| 20212114 | 20078807 | null | 61.7 | Palliative (P) | 2016-10-08 | 2016-10-21 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101239119 |
| 20212115 | 20078808 | 1.71 | null | Palliative (P) | 2021-03-14 | 2021-03-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100063132 |
| 20212116 | 20078809 | 1.77 | 59.9 | Curative (C) | 2016-11-12 | 2016-11-28 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100627340 |
| 20212117 | 20078810 | 1.78 | 68 | Palliative (P) | 2017-10-16 | 2017-10-18 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100830628 |
| 20212118 | 20078811 | 1.76 | 59 | Curative (C) | 2017-10-29 | 2017-11-16 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | CISPLATIN + FLUOROURACIL | 101188584 |
| 20212119 | 20078812 | 1.7 | 68.1 | Curative (C) | 2017-04-03 | 2017-04-16 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100768419 |
| 20212120 | 20078813 | null | null | Palliative (P) | 2018-03-09 | 2018-03-09 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101141477 |
| 20212121 | 20078814 | 0 | 0 | null | 2017-04-10 | 2017-05-11 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101441588 |
| 20212123 | 20078815 | 1.7 | 96 | Adjuvant (A) | 2019-09-21 | 2019-10-01 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101148788 |
| 20212124 | 20078816 | 1.68 | 69 | null | 2019-04-22 | 2019-05-06 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101574246 |
| 20212125 | 20078817 | 1.62 | 77.5 | Palliative (P) | 2019-06-28 | 2019-07-13 | Capecitabine + Carboplatin + RT | N | N | CAPECITABINE + CARBOPLATIN | 100169953 |
| 20212126 | 20078818 | 1.81 | 101.6 | Palliative (P) | 2017-12-06 | 2017-12-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101386554 |
| 20212127 | 20078819 | 1.54 | 91.8 | Palliative (P) | 2016-08-25 | 2016-09-13 | Capecitabine (21days) + Carboplatin | 2 | N | TRIAL UNSPECIFIED | 100531517 |
| 20212128 | 20078820 | 1.7 | 59 | Palliative (P) | 2019-07-10 | 2019-07-24 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101798688 |
| 20212129 | 20078821 | 1.7 | 83 | 03 | 2018-05-27 | 2018-06-03 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100195871 |
| 20212130 | 20078822 | 1.76 | 61 | Palliative (P) | 2017-03-21 | 2017-04-06 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100812351 |
| 20212131 | 20078823 | 1.83 | 51.2 | Neo-adjuvant (N) | 2019-12-24 | 2019-12-26 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101512552 |
| 20212132 | 20078824 | 1.57 | 77.25 | Palliative (P) | 2017-12-30 | 2018-01-01 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101274075 |
| 20212134 | 20078825 | 0 | 0 | Curative (C) | 2018-07-16 | 2018-08-12 | Doxorubicin chemoembolisation | N | Y | DOXORUBICIN EMBOLISATION | 101020470 |
| 20212135 | 20078826 | 1.76 | 75.6 | Neo-adjuvant (N) | 2019-08-13 | 2019-08-22 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100936534 |
| 20212138 | 20078827 | 1.52 | 77.45 | null | 2017-11-28 | 2017-12-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100461963 |
| 20212139 | 20078828 | 1.73 | 75.3 | Palliative (P) | null | 2017-07-31 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100696877 |
| 20212140 | 20078829 | 1.68 | 62.65 | Curative (C) | 2018-10-07 | 2018-10-07 | Cisplatin +Fluorouracil (3 wk) | N | Y | CISPLATIN + FLUOROURACIL | 100705167 |
| 20212141 | 20078830 | 1.75 | 106.1 | Palliative (P) | 2019-03-28 | 2019-04-03 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100257304 |
| 20212142 | 20078831 | 1.44 | 44 | 03 | 2016-10-26 | 2016-11-09 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101371392 |
| 20212143 | 20078832 | 1.72 | 64.8 | Palliative (P) | 2017-02-13 | 2017-02-13 | Cisplatin +Fluorouracil (3 wk) | 2 | N | CISPLATIN + FLUOROURACIL | 100875807 |
| 20212144 | 20078833 | 1.77 | 70.91 | Neo-adjuvant (N) | 2020-12-31 | 2021-01-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100674751 |